Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress
Abstract Hypoxia is increasingly recognized as an important physiological driving force. A specific transcriptional program, induced by a decrease in oxygen (O2) availability, for example, inspiratory hypoxia at high altitude, allows cells to adapt to lower O2 and limited energy metabolism. This tra...
Saved in:
| Main Authors: | Hannelore Ehrenreich, Max Gassmann, Luise Poustka, Martin Burtscher, Peter Hammermann, Anna‐Leena Sirén, Klaus‐Armin Nave, Kamilla Miskowiak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-09-01
|
| Series: | Neuroprotection |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/nep3.15 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tolerability and first hints for potential efficacy of motor‐cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpoint
by: Svea‐Solveig Mennen, et al.
Published: (2024-09-01) -
Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
by: A. M. Kudryashova, et al.
Published: (2021-06-01) -
Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01) -
The Effects of Exercise in Hypoxia and Normoxia Conditions on Endothelin-1 and EPO in Endurance Runners
by: Roohollah Mohammadi Mirzaei
Published: (2020-07-01) -
Myomatous erythrocytosis syndrome: a critical diagnosis in women with uterine leiomyoma: a case report
by: Soheila Aminimoghaddam, et al.
Published: (2025-07-01)